Business Context and Reporting Period
Company: Bruker Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2010
Context: The filing announces the Company's participation in the 28th Annual J.P. Morgan Healthcare Conference. It serves to disclose previously non-public information regarding preliminary, unaudited financial results for the fourth quarter of fiscal 2009 and 2009 order bookings for the Bruker Daltonics subsidiary.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references attached presentation materials (Exhibit 99.1) which contain:
- Preliminary, unaudited revenue estimates for the fourth quarter of fiscal 2009.
- 2009 order bookings data for the Bruker Daltonics subsidiary.
Material Changes
The filing does not detail specific material changes or comparative figures versus prior periods within the text body. It indicates that such data is contained within the attached conference presentation slides.
Guidance, Outlook, and Risks
Management Commentary: The disclosure is made pursuant to Regulation FD to ensure fair disclosure of material non-public information to the market prior to the conference presentation.
Legal Status: The information furnished in this report and its exhibits is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that Section unless specifically incorporated by reference in other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (January 13, 2010 Presentation) for specific Q4 2009 revenue estimates.
- Verify 2009 order bookings figures for the Bruker Daltonics subsidiary in the attached slides.
- Confirm the final audited results in the subsequent 10-K filing to compare against these preliminary estimates.
- Check the Company's investor relations website for the posted presentation materials.